Rossari Biotech Ltd.

₹428.1

23.8 (5.9%)

ROSSARI Share Price

Chemicals & Petrochemicals

As on April 2, 2026

SectorChemicals

IndustryChemicals & Petrochemicals

Basic IndustrySpecialty Chemicals

Market Cap₹ 2,364 Cr

P/E Ratio17.38

Dividend Yield0.06 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	404.87	Bullish
10-DMA	406.69	Bullish
20-DMA	431.31	Bearish
50-DMA	487.19	Bearish
100-DMA	538.2	Bearish
200-DMA	600.05	Bearish

Historical Performance

1 Year

-31.1%

3 Years

-28.2%

5 Years

-60.1%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	20,803	18,306	16,559	14,830	7,093
Total Expenditure	18,261	15,875	14,413	13,067	5,863
Other Income	149	141	139	191	92
Operating Profit	2,691	2,572	2,285	1,954	1,322
Interest	178	194	223	127	30
Depreciation	671	604	629	481	228
Profit Before Tax	1,852	1,776	1,442	1,363	1,068
Consolidated Net Profit	1,364	1,307	1,073	977	802
Adjusted EPS	25	24	19	18	15

Compounded Sales Growth

10 Years:64.8

5 Years:28.2

3 Years:7

TTM:2.6

Compounded Profit Growth

10 Years:105.4

5 Years:15.9

3 Years:6.9

TTM:0.9

Stock Price CAGR

10 Years:N/A

5 Years:-16.8

3 Years:-10.8

TTM:-31.6

Return on Equity

10 Years:0.7

5 Years:15.4

3 Years:19.4

last year:24.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	111	110	110	110	104
Total Reserves	11,722	10,331	9,006	7,909	3,963
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,615	1,930	1,809	2,514	591
Other Current Liabilities	1,446	1,285	1,260	997	174
Short Term Borrowings	861	625	290	---	---
Total Liabilities	21,874	18,246	15,717	14,168	6,448
Capital Work in Progress	1,402	472	131	13	3
Long Term Loans & Advances	1,753	1,705	965	1,087	621
Currents Investments	573	376	260	115	---
Short Term Loans and Advances	2,986	2,254	1,520	1,106	521
Total Current Assets	12,457	10,028	8,474	6,749	3,814
Total Assets	21,874	18,246	15,717	14,168	6,448
Adjusted Book Value	214	189	165	146	78

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 17.38, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of -10.8%, indicating poor shareholder returns.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹2691 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹20803 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 683975.1

No. of Shares: 1598 (Approx)

Performance:-31.6%

P/L: ₹-316024.9

NIFTY Performance: -2.3%

1 day Top Gainers